200 related articles for article (PubMed ID: 12877935)
21. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P
Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730
[TBL] [Abstract][Full Text] [Related]
22. Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning.
Gravius A; Pietraszek M; Schäfer D; Schmidt WJ; Danysz W
Behav Pharmacol; 2005 Mar; 16(2):113-21. PubMed ID: 15767847
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications.
Iso Y; Grajkowska E; Wroblewski JT; Davis J; Goeders NE; Johnson KM; Sanker S; Roth BL; Tueckmantel W; Kozikowski AP
J Med Chem; 2006 Feb; 49(3):1080-100. PubMed ID: 16451073
[TBL] [Abstract][Full Text] [Related]
24. Inducible expression and pharmacological characterization of the mouse metabotropic glutamate 5b receptor.
Salisbury BG; Mukhopadhyay G; Kostich M; Laz TM; Norris ED
Eur J Pharmacol; 2008 Jan; 579(1-3):34-9. PubMed ID: 17967450
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo.
Szydlowska K; Kaminska B; Baude A; Parsons CG; Danysz W
Eur J Pharmacol; 2007 Jan; 554(1):18-29. PubMed ID: 17109843
[TBL] [Abstract][Full Text] [Related]
26. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain.
Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W
Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921
[TBL] [Abstract][Full Text] [Related]
27. Effect of selective antagonists of group I metabotropic glutamate receptors on the micturition reflex in rats.
Guarneri L; Poggesi E; Angelico P; Farina P; Leonardi A; Clarke DE; Testa R
BJU Int; 2008 Sep; 102(7):890-8. PubMed ID: 18489527
[TBL] [Abstract][Full Text] [Related]
28. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Liechti ME; Markou A
Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
[TBL] [Abstract][Full Text] [Related]
29. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems.
Cowen MS; Djouma E; Lawrence AJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):590-600. PubMed ID: 16014750
[TBL] [Abstract][Full Text] [Related]
30. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
Gasparini F; Lingenhöhl K; Stoehr N; Flor PJ; Heinrich M; Vranesic I; Biollaz M; Allgeier H; Heckendorn R; Urwyler S; Varney MA; Johnson EC; Hess SD; Rao SP; Sacaan AI; Santori EM; Veliçelebi G; Kuhn R
Neuropharmacology; 1999 Oct; 38(10):1493-503. PubMed ID: 10530811
[TBL] [Abstract][Full Text] [Related]
31. MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
Morin N; Grégoire L; Morissette M; Desrayaud S; Gomez-Mancilla B; Gasparini F; Di Paolo T
Neuropharmacology; 2013 Mar; 66():355-64. PubMed ID: 22884464
[TBL] [Abstract][Full Text] [Related]
32. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
Nowak G; Pomierny-Chamioło L; Siwek A; Niedzielska E; Pomierny B; Pałucha-Poniewiera A; Pilc A
Neuropharmacology; 2014 Sep; 84():46-51. PubMed ID: 24796254
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus.
Domin H; Zięba B; Gołembiowska K; Kowalska M; Dziubina A; Śmiałowska M
Pharmacol Rep; 2010; 62(6):1051-61. PubMed ID: 21273662
[TBL] [Abstract][Full Text] [Related]
34. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
[TBL] [Abstract][Full Text] [Related]
35. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
Lea PM; Faden AI
CNS Drug Rev; 2006; 12(2):149-66. PubMed ID: 16958988
[TBL] [Abstract][Full Text] [Related]
36. The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception.
Hu Y; Dong L; Sun B; Guillon MA; Burbach LR; Nunn PA; Liu X; Vilenski O; Ford AP; Zhong Y; Rong W
Neurosci Lett; 2009 Jan; 450(1):12-7. PubMed ID: 19027050
[TBL] [Abstract][Full Text] [Related]
37. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD; Ellgren M; Raboisson P
J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
[TBL] [Abstract][Full Text] [Related]
38. Metabotropic glutamate receptor 5 in conditioned taste aversion learning.
Simonyi A; Serfozo P; Parker KE; Ramsey AK; Schachtman TR
Neurobiol Learn Mem; 2009 Oct; 92(3):460-3. PubMed ID: 19439188
[TBL] [Abstract][Full Text] [Related]
39. Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.
Porter RH; Jaeschke G; Spooren W; Ballard TM; Büttelmann B; Kolczewski S; Peters JU; Prinssen E; Wichmann J; Vieira E; Mühlemann A; Gatti S; Mutel V; Malherbe P
J Pharmacol Exp Ther; 2005 Nov; 315(2):711-21. PubMed ID: 16040814
[TBL] [Abstract][Full Text] [Related]
40. Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist.
Jensen J; Lehmann A; Uvebrant A; Carlsson A; Jerndal G; Nilsson K; Frisby C; Blackshaw LA; Mattsson JP
Eur J Pharmacol; 2005 Sep; 519(1-2):154-7. PubMed ID: 16102747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
